company-header-background
新闻中心
阅读我们的最新新闻稿,了解最新产品;媒体咨询请联系市场营销主管 Jane Alleva

LATEST NEWS

Press Release

CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials

Read More

PRESS RELEASES

IN THE NEWS

关注最新动态

立即注册,以便自动接收最新 Precision NanoSystems 应用说明、会议海报、相关科技出版物和网络研讨会邀请函。

MENU
菜单